Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
Not Confirmed
Not Confirmed
30 September-02 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Industry Trade Show
Not Confirmed
30 September-02 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
24 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/24/2952119/0/en/Immutep-Receives-A-3-6-million-R-D-Tax-Incentive-from-French-Government.html
18 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/18/2948165/0/en/New-Data-to-be-Presented-from-EFTISARC-NEO-Phase-II-Evaluating-Novel-Triple-Combination-including-Immutep-s-Efti-in-Soft-Tissue-Sarcoma.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/16/2946575/0/en/Immutep-s-Efti-in-Combination-with-MSD-s-KEYTRUDA-Leads-to-Positive-Efficacy-with-Favourable-Safety-in-First-Line-Head-and-Neck-Cancer.html
20 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/20/2932757/0/en/Immutep-Announces-Late-Breaking-Abstract-in-Head-Neck-Cancer-Selected-for-Oral-Presentation-at-ESMO-Congress-2024.html
14 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/14/2930008/0/en/Immutep-Announces-First-Participant-Dosed-in-Phase-I-Study-of-IMP761-a-First-in-Class-Agonist-LAG-3-Antibody.html
07 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/07/2925899/0/en/Immutep-to-Participate-in-Upcoming-Investor-Conferences.html
ABOUT THIS PAGE
Immutep is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Eftilagimod Alpha bulk offered by Immutep
LOOKING FOR A SUPPLIER?